Clinical Trial Update: Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial update assesses the effects of testosterone treatment on visceral adiposity index and triglyceride-to-HDL cholesterol ratio in individuals with co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hypogonadotropic Hypogonadism
• Hypogonadism

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: Gulhane School of Medicine | Conditions: Hypogonadism | Phase 4 | Status: COMPLETED